Anti-MAG First Administration to Human

Completed

Phase 1 Results N/A

Main Contacts

Name Phone E-mail
GSK Clinical Trials Study Director

Other Locations

Name City State Country Status
GSK Investigational Site Baltimore Maryland United States Unknown_status_icon
GSK Investigational Site Randwick, Sydney New South Wales Australia Unknown_status_icon